QSS
GNCA

Quantitative Systematic Strategies’s Genocea Biosciences, Inc. GNCA Stock Holding History

Quantitative Systematic Strategies’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,420
Closed -$11K – 608
2019
Q1 		$11K Buy
+2,420
New +$12K ﹤0.01% 376

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Quantitative Systematic Strategies's GNCA Position: Q2 2019 in Review

Quantitative Systematic Strategies sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2019, closing a stake of 2,420 shares — an estimated $11K sold.

Quantitative Systematic Strategies first reported a position in GNCA in Q1 2019 and held it in 1 quarter. The position peaked at $11K in Q1 2019. 45 funds tracked by Wall St. Rank hold GNCA as of Q2 2019.

  • Quantitative Systematic Strategies reported no remaining Genocea Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,420 Genocea Biosciences, Inc. shares in Q2 2019, an estimated $11K.
  • Quantitative Systematic Strategies first reported a position in Genocea Biosciences, Inc. in Q1 2019 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Genocea Biosciences, Inc. position peaked at $11K in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2019, filed 25 Jul 2019.